A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
NCT02678793
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
67
Enrollment
INDUSTRY
Sponsor class
Conditions
Morton's Neuroma
Interventions
DRUG:
CNTX-4975
Sponsor
Centrexion Therapeutics